IP Library Granted Patent US 12,365,801
Granted Patent B2
US 12,365,801 · App. 18/621,997 · Granted Jul 22, 2025

Silicon containing detectable compounds and uses thereof

Inventors: Megha Cila (San Diego, CA); Ronald Graham (Carlsbad, CA); Rodrigo Rodriguez (San Diego, CA)
Assignee: Singular Genomics Systems, Inc.
C09B62/365C09K11/06G01N33/582C09K2211/1018
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,365,801
App. No.
18/621,997
Granted
Jul 22, 2025
Kind
B2
Abstract

Disclosed herein, inter alia, are silicon containing detectable compounds and methods of use thereof. In an aspect is provided a monovalent nucleotide or monovalent nucleoside covalently bound to a monovalent form of a compound described herein (e.g., wherein the R13 moiety of a compound described herein has reacted with a bioconjugate reactive group to form a bioconjugate linker thereby covalently bonding the monovalent compound to the monovalent nucleotide or monovalent nucleoside).

Claims (28)

1. A compound, or salt thereof, having the formula:

wherein

R 1 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently hydrogen, halogen, —COOH, —CN, —OH, —NH 2 , —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —N 3 , —PO 3 H, —CH 2 NH 2 , substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl;

R 2 and R 3 are each independently substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl;

R 6 and R 7 are each independently hydrogen, halogen, —OH, —CONH 2 , —SH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;

R 6 and R 7 substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted heteroaryl;

R 7 and R 10 substituents may optionally be joined to form a substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted heteroaryl;

R 6 and R 12 substituents may optionally be joined to form a substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted heteroaryl;

wherein R 1 and R 9 substituents and/or R 8 and R 10 substituents are joined to form a substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocycloalkyl, or substituted or unsubstituted heteroaryl.

2. The compound of claim 1 , wherein R 1 , R 8 , R 9 , R 10 , R 11 , and R 12 are independently —OH, —NH 2 , —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —PO 3 H, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl.

3. The compound of claim 1 , wherein R 1 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently hydrogen, substituted C 1 -C 6 alkyl, unsubstituted 2 to 6 membered heteroalkyl.

4. The compound of claim 1 , wherein R 1 , R 8 , R 9 , R 10 , R 11 , and R 12 are each independently hydrogen, —CH 2 NH 2 , —SO 3 H, or —PO 3 H.

5. The compound of claim 1 , wherein R 6 and R 7 are each independently —OH, —CONH 2 , —SH, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl.

6. The compound of claim 1 , wherein R 2 and R 3 are independently substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted 2 to 6 membered heteroalkyl.

7. The compound of claim 1 , wherein R 2 and R 3 are independently substituted or unsubstituted C 1 -C 6 alkyl.

8. The compound of claim 1 , wherein R 6 and R 7 are independently hydrogen, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted 2 to 6 membered heteroalkyl.

9. The compound of claim 1 , wherein R 6 and R 7 are each independently hydrogen.

10. The compound of claim 1 , wherein R 6 and R 7 substituents bonded to the same nitrogen atom may optionally be joined to form a substituted or unsubstituted 3 to 6 membered heterocycloalkyl.

11. The compound of claim 1 , having the formula:

wherein R 16 and R 17 are each independently halogen, —CCl 3 , —CBr 3 , —CF 3 , —CI 3 , —CHCl 2 , —CHBr 2 , —CHF 2 , —CHI 2 , —CH 2 Cl, —CH 2 Br, —CH 2 F, —CH 2 I, —COOH, —CN, —OH, —NH 2 , —CONH 2 , —NO 2 , —SH, —SO 3 H, —SO 4 H, —SO 2 NH 2 , —NHNH 2 , —ONH 2 , —NHC(O)NHNH 2 , —NHC(O)NH 2 , —NHSO 2 H, —NHC(O)H, —NHC(O)OH, —NHOH, —OCCl 3 , —OCF 3 , —OCBr 3 , —OCl 3 , —OCHCl 2 , —OCHBr 2 , —OCHI 2 , —OCHF 2 , —OCH2Cl, —OCH 2 Br, —OCH 2 I, —OCH 2 F, —N 3 , —SF 5 , —PO 3 H, substituted or unsubstituted alkyl, or substituted or unsubstituted heteroalkyl; and z16 and z17 are each independently an integer from 0 to 4.

12. The compound of claim 11 , wherein R 16 and R 17 are independently —SO 3 H, —SO 4 H, —SO 2 NH 2 , —PO 3 H, substituted or unsubstituted C 1 -C 6 alkyl, or substituted or unsubstituted 2 to 6 membered heteroalkyl.

13. The compound of claim 11 , wherein R 16 and R 17 are independently —CH 2 NH 2 , —SO 3 H, or —PO 3 H.

14. The compound of claim 1 , wherein the compound has a maximum excitation of 500 nm to 700 nm and a maximum emission of 500 nm to 800 nm.

15. A kit comprising a compound of claim 1 .

16. The compound of claim 1 , wherein R 1 and R 9 substituents are joined to form a substituted or unsubstituted C 3 -C 8 cycloalkyl, substituted or unsubstituted C 6 -C 10 aryl; substituted or unsubstituted 3 to 8 membered heterocycloalkyl, or substituted or unsubstituted 5 to 10 membered heteroaryl.

17. The compound of claim 1 , wherein R 1 and R 9 substituents are joined to form a substituted or unsubstituted C 6 aryl.

18. The compound of claim 1 , wherein R 8 and R 10 substituents are joined to form a substituted or unsubstituted C 3 -C 8 cycloalkyl, substituted or unsubstituted C 6 -C 10 aryl; substituted or unsubstituted 3 to 8 membered heterocycloalkyl, or substituted or unsubstituted 5 to 10 membered heteroaryl.

19. The compound of claim 1 , wherein R 8 and R 10 substituents are joined to form a substituted or unsubstituted C 6 aryl.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2024
From: CILA, MEGHA; GRAHAM, RONALD; RODRIGUEZ, RODRIGO
To: SINGULAR GENOMICS SYSTEMS, INC.
Reel/Frame 067469/0038 →
Continuity (5)
Continuation 17882448 · Aug 5, 2022
Continuation 17737899 · May 5, 2022
Continuation PCTUS2020058916 · Nov 4, 2020
Provisional Application 62932296 · Nov 7, 2019
Related Publication 20240279479A1 · Aug 22, 2024
References Cited (61)
US 5268486A · Waggoner et al. · 1993 [cited by applicant]
US 6130101A · Mao et al. · 2000 [cited by applicant]
US 6664079B2 · Ju et al. · 2003 [cited by applicant]
US 9139868B2 · Zhou et al. · 2015 [cited by applicant]
US 9649389B2 · Groves et al. · 2017 [cited by applicant]
US 9714260B2 · Nagano et al. · 2017 [cited by applicant]
US 9933417B2 · Lavis et al. · 2018 [cited by applicant]
US 10087199B2 · Erdmann et al. · 2018 [cited by applicant]
US 10564164B2 · Majima et al. · 2020 [cited by applicant]
US 10738072B1 · Graham et al. · 2020 [cited by applicant]
US 11180657B2 · Kemnitzer et al. · 2021 [cited by applicant]
US 11535754B2 · Cila et al. · 2022 [cited by applicant]
US 11697736B2 · Graham et al. · 2023 [cited by applicant]
US 11987709B2 · Cila et al. · 2024 [cited by applicant]
US 20040096825A1 · Chenna et al. · 2004 [cited by applicant]
US 20100009353A1 · Barnes et al. · 2010 [cited by applicant]
US 20140272990A1 · Zhou et al. · 2014 [cited by applicant]
US 20140342384A1 · Nagano et al. · 2014 [cited by applicant]
US 20150353585A1 · Nagano et al. · 2015 [cited by applicant]
US 20160115180A1 · Erdmann et al. · 2016 [cited by applicant]
US 20170363636A1 · Majima et al. · 2017 [cited by applicant]
US 20190100653A1 · Kemnitzer et al. · 2019 [cited by applicant]
US 20190352508A1 · Graham et al. · 2019 [cited by applicant]
US 20220267603A1 · Cila et al. · 2022 [cited by applicant]
US 20220332752A2 · Graham et al. · 2022 [cited by applicant]
US 20230101281A1 · Cila et al. · 2023 [cited by applicant]
US 20230295437A1 · Graham et al. · 2023 [cited by applicant]
EP 3461815A1 · 2019 [cited by applicant]
WO WO2019222653A1 · 2019 [cited by applicant]
WO WO2020005172A2 · 2020 [cited by applicant]
WO 2020033681A2 · 2020 [cited by applicant]
WO 2021092035A1 · 2021 [cited by applicant]
Bentley, D. R. et al. (Nov. 6, 2008). “Accurate whole human genome sequencing using reversible terminator chemistry,” [cited by applicant]
Berlier, J. E. et al. (Dec. 2003). “Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates,” [cited by applicant]
Birtalan, E. et al. (Mar. 1, 2011). “Investigating rhodamine B-labeled peptoids: Scopes and limitations of its applications,” [cited by applicant]
Brauch, S. et al. (Oct. 25, 2011). “Fast and efficient MCR-based synthesis of clickable rhodamine tags for protein profiling,” [cited by applicant]
Buckley, M. et al. (Jan. 2016, e-published Dec. 10, 2015). “Enhancer scanning to locate regulatory regions in genomic loci,” [cited by applicant]
Choi, A. et al. (Aug. 3, 2018, e-published Jul. 17, 2018). “Silicon substitution in oxazine dyes yields near-infrared azasiline fluorophores that absorb and emit beyond 700 nm,” [cited by applicant]
Extended European Search Report mailed on Jan. 31, 2022, for EP Patent Application No. EP19803002.5, 9 pages. [cited by applicant]
Goldstein, S. W. et al. (Sep. 12, 2017, e-published Jul. 28, 2017). “Nucleophilic aromatic substitution-addition and identification of an amine,” [cited by applicant]
Grimm, J. B. et al. (Sep. 27, 2017, e-published Aug. 9, 2017). “General Synthetic Method for Si-Fluoresceins and Si-Rhodamines,” [cited by applicant]
Guo, J. et al. (Jul. 8, 2008, e-published Jun. 30, 2008). “Four-color DNA sequencing with 3′-O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides,” [cited by applicant]
Hutter, D. et al. (Nov. 2010, e-published Dec. 1, 2010). “Labeled nucleoside triphosphates with reversibly terminating aminoalkoxyl groups,” [cited by applicant]
International Search Report and Written Opinion mailed on Feb. 8, 2021, for PCT application PCT/US2020/058916, filed Nov. 4, 2020, 6 pages. [cited by applicant]
International Search Report and Written Opinion mailed on Oct. 24, 2019, for PCT Application No. PCT/US2019/032907, filed May 17, 2019, 9 pages. [cited by applicant]
Ju, J. et al. (Dec. 26, 2006, e-published Dec. 14, 2006). “Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators,” [cited by applicant]
Koide, Y. et al. (Mar. 21, 2012, e-published Mar. 7, 2012). “Development of NIR fluorescent dyes based on Si-rhodamine for in vivo imaging,” [cited by applicant]
Kolmakov, K. et al. (Sep. 14, 2015, e-published Aug. 13, 2015) “Far-Red Emitting Fluorescent Dyes for Optical Nanoscopy: Fluorinated Silicon-Rhodamines (SiRF Dyes) and Phosphorylated Oxazines” [cited by applicant]
Leicher, T. et al. (Dec. 25, 1998). “Coexpression of the KCNA3B gene product with Kv1.5 leads to a novel A-type potassium channel,” [cited by applicant]
Mathews, A. S. et al. (Aug. 9, 2016). “Photo-cleavable nucleotides for primer free enzyme mediated DNA synthesis,” [cited by applicant]
Needleman, S. B. et al. (Mar. 28, 1970, e-published Oct. 28, 2004). “A general method applicable to the search for similarities in the amino acid sequence of two proteins,” [cited by applicant]
Pearson, W. R. et al. (Apr. 1, 1988). “Improved tools for biological sequence comparison,” [cited by applicant]
Randolph, J. B. et al. (Jul. 1, 1997). “Stability, specificity and fluorescence brightness of multiply-labeled fluorescent DNA probes,” [cited by applicant]
Rosenblum, B.B. et al. (Nov. 1, 1997). “New dye-labeled terminators for improved DNA sequencing patterns,” [cited by applicant]
Ruparel, H. et al. (Apr. 26, 2005, e-published Apr. 13, 2005). “Design and synthesis of a 3′-0-allyl photocleavable fluorescent nucleotide as a reversible terminator for DNA sequencing by synthesis,” [cited by applicant]
Shen, S. et al. (Feb. 9, 2017). “Near-infrared probes based on fluorinated Si-rhodamine for live cell imaging,” [cited by applicant]
Smith T. F. et al. (Dec. 1981, e-published Sep. 3, 2004). “Comparison of biosequences,” [cited by applicant]
Wu, J. et al. (Oct. 16, 2007, e-published Oct. 8, 2007). “3′-O-modified nucleotides as reversible terminators for pyrosequencing,” [cited by applicant]
Xu, H. et al. (May 19, 2016). “Cellular thermal shift and clickable chemical probe assays for the determination of drug-target engagement in live cells,” [cited by applicant]
Zhu, Z. et al. (Aug. 25, 1994). “Directly labeled DNA probes using fluorescent nucleotides with different length linkers,” [cited by applicant]
Rogers, Kara (2023) “Biomolecule”, https://www.britannica.com/science/biomolecule, 4 pages. [cited by applicant]